ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1129

Transthyretin Deposition Accelerates the Development of Experimental Osteoarthritis in Mice

Tokio Matsuzaki1, Oscar Alvarez-Garcia2, Yukio Akasaki3, Natalia Reixach4, Joel Buxbaum2 and Martin K. Lotz5, 1Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, 2The Scripps Research Institute, La Jolla, CA, 3Kyushu University, Fukuoka, Japan, 4Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, 5Division of Arthritis, The Scripps Research Institute, La Jolla, CA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: cartilage and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Biology and Pathology of Bone and Joint Poster I: Osteoarthritis Pathogenesis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Deposition of amyloid is a common aging-associated phenomenon and a key factor in the pathogenesis of several aging-related diseases. Osteoarthritis (OA) is the most prevalent joint disease and aging is its major risk factor. Transthyretin (TTR) is an amyloidogenic protein. We previously reported that amyloid and TTR deposition were increased in human OA cartilage with aging and OA grade. In addition, amyloidogenic TTR affected chondrocyte survival and induced the OA related genes such as ADAMTS4, interleukin 6 and inducible nitric oxide synthase. Here we investigated the role of TTR in vivo. Transgenic mice for wild-type human TTR (hTTR TG mice) were analyzed using an experimental OA model.

Methods:

TTR in cartilage and chondrocytes was analyzed by immunohistochemistry and Western blotting. OA was surgically induced by destabilizing the medial meniscus of the hTTR TG mice (n=26) and control mice (n=22). Mice were sacrificed 10 weeks after surgery. To investigate the effects of TTR on cartilage, 6-month-old mice were sacrificed and examined by immunohistochemistry, real-time PCR and Western blotting. In addition, quantitative analysis of cell number in cartilage was examined in 6-, 12-month-old mice, and surgical model. OA-related tissue changes were evaluated using the Glasson’s semi-quantitative cartilage scoring system and Krenn’s synovitis score.

Results:

TTR protein was detected in cartilage in hTTR TG mice, but chondrocytes did not express TTR mRNA, the transgene was highly overexpressed in the liver. ADAMTS4 and MMP13 mRNA were significantly elevated in cartilage in 6 month-old hTTR TG mice compared with control mice. Immunohistochemical and Western blotting analysis showed increased MMP13 expression in the hTTR TG mice 10 weeks after surgery compared with control mice. In addition, nuclear factor-κB (NF-κB) p65 and Phospho-NF-κB p65 was elevated in hTTR TG mice. In the surgical model, both histological OA score and synovitis score were significantly increased in hTTR TG mice. Additionally, cellularity was significantly lower in the 6-month-old hTTR TG mice and hTTR TG mice with surgical OA compared with control mice.

Conclusion:

These findings are the first to show that TTR deposition accelerated the development of OA in the surgically-induced murine OA model. Our observations suggested that reducing TTR amyloid formation can be a new therapeutic approach for OA.


Disclosure: T. Matsuzaki, None; O. Alvarez-Garcia, None; Y. Akasaki, None; N. Reixach, None; J. Buxbaum, None; M. K. Lotz, None.

To cite this abstract in AMA style:

Matsuzaki T, Alvarez-Garcia O, Akasaki Y, Reixach N, Buxbaum J, Lotz MK. Transthyretin Deposition Accelerates the Development of Experimental Osteoarthritis in Mice [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/transthyretin-deposition-accelerates-the-development-of-experimental-osteoarthritis-in-mice/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/transthyretin-deposition-accelerates-the-development-of-experimental-osteoarthritis-in-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology